Description A recombinant human monoclonal antibody that is designed to bind to Neuropilin-1 (NRP1).

Development Status Phase I clinical trials evaluating anti-NRP1 for solid tumors are ongoing.

Additional Information on Clinical Trials For inquiries about our clinical trials, please submit a request through our information request form or call (888) 662-6728.

National Institutes of Health Website: www.clinicaltrials.gov

November 2009